Promotion of nitric oxide production: mechanisms, strategies, and possibilities

The discovery of nitric oxide (NO) and the role of endothelial cells (ECs) in its production has revolutionized medicine. NO can be produced by isoforms of NO synthases (NOS), including the neuronal (nNOS), inducible (iNOS), and endothelial isoforms (eNOS), and via the non-classical nitrate-nitrite-...

Full description

Saved in:
Bibliographic Details
Main Authors: Marcos Gonzalez, Sarah Clayton, Eric Wauson, Daniel Christian, Quang-Kim Tran
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2025.1545044/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590827087462400
author Marcos Gonzalez
Sarah Clayton
Eric Wauson
Daniel Christian
Quang-Kim Tran
author_facet Marcos Gonzalez
Sarah Clayton
Eric Wauson
Daniel Christian
Quang-Kim Tran
author_sort Marcos Gonzalez
collection DOAJ
description The discovery of nitric oxide (NO) and the role of endothelial cells (ECs) in its production has revolutionized medicine. NO can be produced by isoforms of NO synthases (NOS), including the neuronal (nNOS), inducible (iNOS), and endothelial isoforms (eNOS), and via the non-classical nitrate-nitrite-NO pathway. In particular, endothelium-derived NO, produced by eNOS, is essential for cardiovascular health. Endothelium-derived NO activates soluble guanylate cyclase (sGC) in vascular smooth muscle cells (VSMCs), elevating cyclic GMP (cGMP), causing vasodilation. Over the past four decades, the importance of this pathway in cardiovascular health has fueled the search for strategies to enhance NO bioavailability and/or preserve the outcomes of NO’s actions. Currently approved approaches operate in three directions: 1) providing exogenous NO, 2) promoting sGC activity, and 3) preventing degradation of cGMP by inhibiting phosphodiesterase 5 activity. Despite clear benefits, these approaches face challenges such as the development of nitrate tolerance and endothelial dysfunction. This highlights the need for sustainable options that promote endogenous NO production. This review will focus on strategies to promote endogenous NO production. A detailed review of the mechanisms regulating eNOS activity will be first provided, followed by a review of strategies to promote endogenous NO production based on the levels of available preclinical and clinical evidence, and perspectives on future possibilities.
format Article
id doaj-art-8a9d614f7c2d409081c53bc0c70e0173
institution Kabale University
issn 1664-042X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj-art-8a9d614f7c2d409081c53bc0c70e01732025-01-23T06:56:28ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2025-01-011610.3389/fphys.2025.15450441545044Promotion of nitric oxide production: mechanisms, strategies, and possibilitiesMarcos GonzalezSarah ClaytonEric WausonDaniel ChristianQuang-Kim TranThe discovery of nitric oxide (NO) and the role of endothelial cells (ECs) in its production has revolutionized medicine. NO can be produced by isoforms of NO synthases (NOS), including the neuronal (nNOS), inducible (iNOS), and endothelial isoforms (eNOS), and via the non-classical nitrate-nitrite-NO pathway. In particular, endothelium-derived NO, produced by eNOS, is essential for cardiovascular health. Endothelium-derived NO activates soluble guanylate cyclase (sGC) in vascular smooth muscle cells (VSMCs), elevating cyclic GMP (cGMP), causing vasodilation. Over the past four decades, the importance of this pathway in cardiovascular health has fueled the search for strategies to enhance NO bioavailability and/or preserve the outcomes of NO’s actions. Currently approved approaches operate in three directions: 1) providing exogenous NO, 2) promoting sGC activity, and 3) preventing degradation of cGMP by inhibiting phosphodiesterase 5 activity. Despite clear benefits, these approaches face challenges such as the development of nitrate tolerance and endothelial dysfunction. This highlights the need for sustainable options that promote endogenous NO production. This review will focus on strategies to promote endogenous NO production. A detailed review of the mechanisms regulating eNOS activity will be first provided, followed by a review of strategies to promote endogenous NO production based on the levels of available preclinical and clinical evidence, and perspectives on future possibilities.https://www.frontiersin.org/articles/10.3389/fphys.2025.1545044/fullnitric oxideeNOSendotheliumpreclinical evidenceclinical trials
spellingShingle Marcos Gonzalez
Sarah Clayton
Eric Wauson
Daniel Christian
Quang-Kim Tran
Promotion of nitric oxide production: mechanisms, strategies, and possibilities
Frontiers in Physiology
nitric oxide
eNOS
endothelium
preclinical evidence
clinical trials
title Promotion of nitric oxide production: mechanisms, strategies, and possibilities
title_full Promotion of nitric oxide production: mechanisms, strategies, and possibilities
title_fullStr Promotion of nitric oxide production: mechanisms, strategies, and possibilities
title_full_unstemmed Promotion of nitric oxide production: mechanisms, strategies, and possibilities
title_short Promotion of nitric oxide production: mechanisms, strategies, and possibilities
title_sort promotion of nitric oxide production mechanisms strategies and possibilities
topic nitric oxide
eNOS
endothelium
preclinical evidence
clinical trials
url https://www.frontiersin.org/articles/10.3389/fphys.2025.1545044/full
work_keys_str_mv AT marcosgonzalez promotionofnitricoxideproductionmechanismsstrategiesandpossibilities
AT sarahclayton promotionofnitricoxideproductionmechanismsstrategiesandpossibilities
AT ericwauson promotionofnitricoxideproductionmechanismsstrategiesandpossibilities
AT danielchristian promotionofnitricoxideproductionmechanismsstrategiesandpossibilities
AT quangkimtran promotionofnitricoxideproductionmechanismsstrategiesandpossibilities